NRx
Northscript Partners Pharmacy Acquisitions · Canada

Toronto, Ontario · Canada-wide

We buy independent
Canadian pharmacies —
with our own capital.

Northscript Partners is a principal buyer, not a brokerage. There is no listing, no commission, and no auction. Start with a confidential conversation with the person who actually writes the check.

Confidential by default. Nothing is shared with staff, banners, or competitors.
Prefer to talk? Call (647) 584-4014.

NRx

What you get from a first call

  • A straight answer on whether your pharmacy fits what we buy
  • How we think about value — and what drives it up or down
  • What a transition could look like for your staff and patients
  • No obligation, no listing agreement, no fee to you, no one will know.
Confidential process No commission Talk to principals, not brokers Direct, fast answers

Our approach

A buyer on the other side of the table — not a middleman in between.

Most owners who explore a sale end up talking to intermediaries first. We are the buyer. That changes the conversation: fewer parties, less disclosure, and a decision that does not have to travel through anyone else.

Your name stays out of the market

No listing, no teaser, no broadcast to a buyer list. We speak with you directly, and nothing moves without your say-so.

You keep the proceeds

We charge you nothing. There is no success fee, no retainer, and no percentage carved out of your proceeds on the way to closing.

We are long-term owners

We are building a group of community pharmacies to hold forever. Your team, your patients, and your banner relationships matter to how we underwrite.

What we do

Two ways we invest in pharmacies

Not every owner wants a 100% exit, but some do. In both cases we are the source of capital — we are never acting as an agent for someone else's transaction.

Option one

We buy your pharmacy

A direct purchase of the business, in full or in stages, funded by us.

  • Full exit. You sell and step away on a timeline that works for you.
  • Phased exit. Sell the majority now, keep a slice, and stay on as long as you want to.
  • Stay-on option. Some owners want to keep dispensing without owning the headaches. That works.
  • Retirement transitions. We build the closing around your province's accreditation and licensing steps, not against them.
Option two

We fund your successor

You have a buyer in mind — an associate, a junior partner, a family member — but they cannot fund it alone.

  • We supply the capital so a pharmacist you trust can buy in alongside us.
  • You get liquidity now rather than waiting years for a slow internal buyout.
  • Your successor gets real ownership and a partner behind them, not just a loan.
  • We do not broker this. We are the money on one side of the table, with skin in the game.

Are you a pharmacist who wants to own rather than sell? We also back entrepreneurial pharmacists into ownership. Tell us what you're looking for →

What we look for

The kind of pharmacy that fits.

These are guidelines, not gates. If your pharmacy sits outside them and the story is good, we would still like to hear it.

Independent
Owner-operated community pharmacies, banner or unbanned. Single stores and small groups.
Canada
Ontario is our first focus, with the rest of the country open to us.
Steady scripts
A stable, recurring prescription base matters more to us than headline revenue.
A real team
Staff who know the patients. We are buying continuity, not just a dispensary.

The process

Direct conversations, not a four-month auction.

NDA before anything else

We understand how important confidentiality is.

An introductory call

Thirty minutes, entirely confidential, no documents required. You tell us about the pharmacy; we tell you honestly whether it fits and how we would think about it.

The numbers

Financial statements, a script count, the lease, and a payroll summary are a first step to figure out what we can do.

An indicative offer in writing

Price, structure, what happens to your staff, and what we would need from you during the transition — all on paper, so you can take it to your accountant.

Diligence

We do the work quietly with your advisors. Staff and patients do not know you are looking at a deal (unless you want them to).

Close

We target to close in 90 days or less. We can move fast; we've done this before.

Transition

You set the agenda — how do we communicate with staff and community.

Every deal moves at the pace the owner sets, and regulatory and licensing steps vary by province.

Questions owners ask

Straight answers.

Are you a broker?

No. We are a principal buyer and capital provider. We buy pharmacies for our own account and we invest alongside pharmacist owners. We do not list pharmacies, we do not represent sellers, and we do not take a commission from anyone.

What does it cost me to talk to you?

Nothing. There is no retainer, no listing agreement, and no fee if we transact. You should still have your own accountant and lawyer review anything we put in front of you — and we would think less of you if you didn't.

Will my staff find out?

Not from us. Confidentiality is the whole reason most owners talk to a direct buyer instead of running a process. We sign a mutual NDA before we look at anything, and we take direction from you on when and how anyone else is told.

I'm not ready to sell for a few years. Is it too early to talk?

That is the best time to talk. The things that raise a pharmacy's value — clean books, a documented team, script mix, lease term — are easier to fix with two years of runway than with two months. There is no cost to starting the conversation early.

Can I keep working after the sale?

Yes, and many owners want to. Some stay on as the pharmacist-manager, some keep a minority stake, some hand over the keys and leave. We are flexible on this because continuity is worth real money to us.

How do you think about price?

We underwrite on sustainable cash flow, not on a rule of thumb, and we would rather explain our math to you than hide behind a formula. What we will say up front: we do not pay for earnings we do not believe will still be there in three years, and we do pay for a business that runs without its owner in the building.

Who is behind Northscript Partners?

We are a Toronto-based group with a background in mergers, acquisitions, and operations, building a long-term portfolio of Canadian community pharmacies. You will deal with a principal from the first call, not an associate or a call center.

Ask us to contact you

Start a confidential conversation.

Fill this in and we will reach out personally, usually within one business day. Your information is sent directly to us — nothing is stored publicly.

Rather just pick up the phone? Call (647) 584-4014 — it rings a principal, not a switchboard. Or book a time that works for you.

Please enter your name.
Please enter a valid email address.
Please tell us roughly where you are.

Your information is sent securely and directly to our team. We do not share your information with anyone.

Thank you — we'll be in touch.

We reply personally, usually within one business day. Nothing you've shared will be disclosed to anyone outside of our team.

Sign our mutual NDA

Before we review any documents, both parties sign a mutual NDA. You can sign it now to get things started — or wait until our first call.

MUTUAL NON-DISCLOSURE AGREEMENT

This Mutual Non-Disclosure Agreement ("Agreement") is entered into as of the date of the last signature below (the "Effective Date") by and between:

Northscript Partners ("Northscript"), with offices in Toronto, Ontario;

and

________________________________ (the "Owner"), an individual or entity operating an independent pharmacy business in Canada.

Northscript and the Owner are each referred to as a "Party" and collectively as the "Parties."

RECITALS

The Parties wish to explore a potential transaction involving the Owner's pharmacy business (the "Purpose"). In connection with the Purpose, each Party may disclose Confidential Information (as defined below) to the other. The Parties enter into this Agreement to protect the confidentiality of that information.

1. DEFINITION OF CONFIDENTIAL INFORMATION

"Confidential Information" means any non-public information disclosed by either Party to the other, whether in writing, orally, electronically, or by inspection, in connection with the Purpose, including but not limited to:

(a) financial statements, tax returns, and accounting records;
(b) prescription volumes, patient counts, and dispensing data;
(c) employee and staffing information;
(d) lease terms and property details;
(e) supplier and wholesale agreements;
(f) business plans, strategies, and proprietary methods;
(g) the existence and content of any discussions, offers, or negotiations between the Parties; and
(h) any analysis, compilation, or summary prepared by the receiving Party that contains or reflects Confidential Information.

2. EXCLUSIONS

Confidential Information does not include information that:

(a) is or becomes publicly available through no fault of the receiving Party;
(b) was already known to the receiving Party prior to disclosure, as demonstrated by written records;
(c) is independently developed by the receiving Party without use of or reference to the disclosing Party's Confidential Information; or
(d) is lawfully received from a third party without restriction on disclosure.

3. OBLIGATIONS OF THE RECEIVING PARTY

Each Party, as a recipient of Confidential Information, agrees to:

(a) hold all Confidential Information in strict confidence;
(b) not disclose Confidential Information to any person other than its directors, officers, employees, professional advisors and financing sources who have a need to know for the Purpose and who are bound by obligations of confidentiality no less protective than those in this Agreement ("Representatives");
(c) not use Confidential Information for any purpose other than the Purpose;
(d) exercise at least the same degree of care in protecting Confidential Information as it uses to protect its own confidential information, and in any event no less than reasonable care; and
(e) be responsible for any breach of this Agreement by its Representatives.

4. NO DISCLOSURE OF DISCUSSIONS

Neither Party shall disclose to any third party the fact that Confidential Information has been exchanged, that discussions or negotiations are taking place, or any terms or conditions being discussed, without the prior written consent of the other Party.

5. COMPELLED DISCLOSURE

If either Party is required by applicable law, regulation, or legal process to disclose Confidential Information, it shall (to the extent legally permitted) provide the other Party with prompt written notice so that the disclosing Party may seek a protective order or other appropriate remedy.

6. RETURN OR DESTRUCTION

Upon written request by either Party, or upon termination of discussions, the receiving Party shall promptly return or destroy all Confidential Information and any copies thereof, and shall certify such return or destruction in writing upon request.

7. NO OBLIGATION TO TRANSACT

Nothing in this Agreement obligates either Party to enter into any transaction, continue discussions, or disclose any particular information.

8. NO WARRANTY

All Confidential Information is provided "as is." The disclosing Party makes no representation or warranty, express or implied, as to the accuracy, completeness, or fitness for a particular purpose of any Confidential Information.

9. REMEDIES

Each Party acknowledges that a breach of this Agreement may cause irreparable harm for which monetary damages would be an inadequate remedy. Accordingly, either Party may seek injunctive or other equitable relief in addition to any other remedies available at law or in equity.

10. TERM

This Agreement shall remain in effect for a period of two (2) years from the Effective Date. The obligations of confidentiality shall survive termination or expiration of this Agreement for a further period of two (2) years.

11. GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein.

12. ENTIRE AGREEMENT

This Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior or contemporaneous understandings, whether written or oral. This Agreement may not be amended except by a written instrument signed by both Parties.

13. COUNTERPARTS

This Agreement may be executed in counterparts, each of which shall be deemed an original. Electronic or digital signatures shall be deemed original signatures for all purposes.

By typing your name above you agree to the terms of this mutual non-disclosure agreement. Northscript Partners will countersign and return a copy.

NDA signed

We have your signature on file and will countersign on our first call. Download a copy for your records.

Download NDA (PDF)